Lifecore Biomedical, Inc.
Investors that purchased the Company’s securities and have suffered a loss, please fill in transaction information below, or email to info@portnoylaw.com.
There is no cost or obligation associated with submitting your information. If you are a shareholder who suffered a loss, please submit your contact information and purchase information to participate in the putative class action.
We also encourage you to contact Lesley F. Portnoy of The Portnoy Law Firm, at 310.692.8883, to discuss your rights free of charge. You can also reach us through the firm’s website at www.portnoylaw.com, or by email at info@portnoylaw.com.
If you choose to take no action, you can remain an absent class member.
Joining the case through the Portnoy Law website enables investors to learn about their legal claims and take an active role in recovering their losses.
The Portnoy Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
CONTACT:
Portnoy Law Firm
Lesley F. Portnoy, Esq.,
www.portnoylaw.com
Office: 310.692.8883
1800 Century Park East, Suite 600
Los Angeles, CA 90067
info@portnoylaw.com
According to the lawsuit, during the Class Period, the defendants allegedly made false or misleading statements and/or failed to disclose that: (1) Lifecore had inadequate internal controls over financial reporting; (2) as a result, Lifecore issued several inaccurate financial statements that would need to be corrected; (3) Lifecore’s efforts to address these deficiencies were ineffective; (4) these issues hindered Lifecore’s ability to file periodic reports with the Securities and Exchange Commission on time and meet NASDAQ listing requirements; (5) as a result, Lifecore’s financial position and outlook were significantly overstated; and (6) consequently, Lifecore’s public statements were materially false and misleading throughout the relevant period. The lawsuit claims that investors suffered damages once the true details became known.
